Today: 26 April 2026
Visa Inc. Stock Faces a Crucial Earnings Test After Wall Street Cuts Its Target
26 April 2026
2 mins read

Visa Inc. Stock Faces a Crucial Earnings Test After Wall Street Cuts Its Target

SAN FRANCISCO, April 26, 2026, 09:00 (PDT)

  • Visa is set to release its fiscal second-quarter earnings Tuesday, following the closing bell.
  • Truist trimmed its price target for Visa down to $361 from the previous $372, while sticking with its Buy rating.
  • The report puts card spending and cross-border transactions under the microscope, checking if both remain resilient.

Visa Inc. is set to report its fiscal second-quarter results this week, with analysts eyeing fresh signals on consumer spending. Truist trimmed its price target for the payments giant but maintained its positive rating on the shares.

Timing is key here. Visa will release its results April 28 after markets close—an early read for investors tracking card spending, travel trends, and e-commerce before more retail data hits. According to the company, results will go up with the SEC and on its investor relations site, followed by a webcast at 2 p.m. Pacific.

Truist trimmed its Visa price target down to $361 from $372 while sticking with a Buy, TipRanks wrote, citing The Fly. The note pointed to a “mostly positive” earnings set-up—U.S. bank results hint at volume upside for payments, consumer spending looks solid heading into 2026, and Visa’s valuation has come down after a stretch of underperformance. TipRanks

Visa is forecast to post earnings of $3.10 per share on roughly $10.74 billion in revenue, per Benzinga data. The stock finished Friday’s session at $309.42, a 0.17% gain, though it dipped a bit in after-hours trade.

Visa turned in strong numbers last quarter. Net revenue climbed 15% to $10.9 billion in the fiscal first, and non-GAAP earnings landed at $3.17 per share. Investors often prefer those non-GAAP results, which exclude one-time or accounting adjustments, for a clearer look at core performance.

Visa’s core metrics held up. In the quarter through Dec. 31, payments volume climbed 8% in constant dollars, while cross-border volume — excluding intra-Europe — added 11%. Processed transactions increased 9%, reaching 69.4 billion. Cross-border volume matters for Visa, since it reflects spending that crosses national borders, from travel to global e-commerce.

Back in January, Chief Executive Ryan McInerney pointed to “resilient consumer spending and a strong holiday season,” along with gains in value-added services and money movement products, as key to the quarter’s results. Investors are watching to see if those trends held up after the holidays, with management expected to offer more detail on Tuesday about the current pace of U.S. spending. SEC

But Visa isn’t the whole story. Mastercard, its main public rival, drops first-quarter numbers on April 30, with a 9 a.m. Eastern conference call lined up. That’s just two days after Visa, so investors will be watching for fresh details on payment flows, cross-border trends and merchant behavior.

Still, risks linger. A pullback from consumers, any slowdown in travel outlays, or a jump in costs—all could blunt what might otherwise be a solid profit beat, even if revenues line up with forecasts. And then there’s the regulatory front: Visa faces a Justice Department suit from 2024, which alleges the company stifled debit processing competition. Visa has pushed back, calling the allegations baseless and pledging to fight them.

Right now, the next swing for the stock looks tied less to Visa beating earnings by a narrow margin and more to whatever the company reveals about April volumes, cross-border trends, and network defense spending. Investors have listened to the resilience pitch before. This time, they’re looking for new evidence.

Stock Market Today

  • Cramer Highlights Risks of Concentrated AI Stock Investments and Healthcare Sector Decline
    April 26, 2026, 1:06 PM EDT. Jim Cramer warns the stock market faces a shortage of broad investment as funds disproportionately flow into AI-related stocks tied to data center buildouts. This concentration has left sectors like defense and healthcare, particularly pharmaceuticals and life sciences, under severe pressure. Companies such as Thermo Fisher and Danaher face harsh market reactions despite solid fundamentals and quarterly results. Medical device maker Abbott Labs and drug distributor Cardinal Health also grapple with declining stock prices, reflecting a wider investor retreat from healthcare. Even Johnson & Johnson, despite strong earnings, has seen its stock drop due to poor technical charts. Cramer suggests that increasing overall market inflows could stabilize these struggling sectors and bring balance to the current investment landscape.

Latest article

COHR Stock Faces a May Test After CFO’s $702,000 Sale

COHR Stock Faces a May Test After CFO’s $702,000 Sale

26 April 2026
Coherent Corp CFO Sherri Luther sold 2,000 shares for $702,000 on April 22, according to an SEC filing. The sale comes ahead of Coherent’s fiscal third-quarter results, set for May 6. Coherent shares last traded at $336.09, below Luther’s sale price of $351. Nvidia invested $2 billion in Coherent in March, securing future access to laser and optical networking products.
Trump Media Shake-Up Deepens: DJT Board Adds Trump Allies as New CEO Gets Stock Grant

Trump Media Shake-Up Deepens: DJT Board Adds Trump Allies as New CEO Gets Stock Grant

26 April 2026
Trump Media disclosed interim CEO Kevin McGurn will earn $125,000 a month for nine months and receive 146,198 restricted stock units, according to a Friday filing. Meredith O’Rourke and Boris Epshteyn joined the board effective April 24. Devin Nunes has exited all roles, with separation terms including accelerated vesting of 96,721 RSUs. DJT shares last traded at $9.35.
AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?

AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?

26 April 2026
AXT underwriters bought 1.28 million additional shares at $64.25 each, raising $82.5 million and bringing total gross proceeds to about $632.5 million. The funds will expand indium phosphide wafer capacity at Beijing Tongmei, its China-based subsidiary. AXT expects first-quarter revenue of $26–28 million and a net loss of up to $2.6 million. Shares closed at $76.16 on April 24.
Lightwave Logic Stock Drop Puts $51 Million Share-Sale Plan and AI Optics Push in Focus
Previous Story

Lightwave Logic Stock Drop Puts $51 Million Share-Sale Plan and AI Optics Push in Focus

AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?
Next Story

AXT Stock Has a $632.5 Million Question: Can Its China Wafer Bet Keep Up With AI Demand?

Go toTop